Beijing, Beijing, China Related Funds
Funds with similar focus
| Fund Name | Location |
| Avista | Spokane, United States, Washington |
| China Chengxin Credit | Beijing, Beijing, China |
| Deep Ventures | California, San Francisco, United States |
| DHI Group, Inc. | New York, New York, United States |
| DOCOMO InsightMarketing | Japan, Toshima |
| Ever Sunny | China, Hong Kong, Hong Kong Island |
| Gilead Sciences | California, Foster City, United States |
| Hua Hsia Investment Holding Co | Taipei, Taiwan |
| Interact for Health | Cincinnati, Ohio, United States |
| JSR Corp | Chiyoda, Japan |
| Kaiyuan Securities Capital Management | China, Henan, Shanxi |
| LDGR Ventures | - |
| Northrop Grumman | Falls Church, United States, Virginia |
| Rosemont Investment Partners | Conshohocken, Pennsylvania, United States |
| Rowad | - |
| Shanda Interactive Entertainment Limited | China, Shanghai |
| Weijia Investment | China, Ningbo, Zhejiang |
| Whitman Capital | California, Palo Alto, United States |
| Xenon Ventures | Beaverton, Oregon, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Wuyou Xingyao | $10M | 28 Aug 2023 | Hangzhou, Zhejiang, China | ||
Singlomics | $46M | 02 Feb 2022 | Beijing, Beijing, China | ||
Innovative Cellular Therapeutics | $28M | 25 Apr 2018 | Shanghai, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Wuyou Xingyao | $10M | 28 Aug 2023 | Hangzhou, Zhejiang, China | ||
Singlomics | $46M | 02 Feb 2022 | Beijing, Beijing, China | ||
Innovative Cellular Therapeutics | $28M | 25 Apr 2018 | Shanghai, China |
